Kursprognose für NovaBridge Biosciences (NBP)NBPNovaBridge Biosciences

Alphio's NBP stock price prediction model matches the current NovaBridge Biosciences tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.92 (+0.87%). The 1-week path is $0.92 (+1.38%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Given the current price of $1.07 and a 52-week high of $5.19, NBP has significant downside risk. The RSI is at 20.514, indicating the stock is oversold but also reflects a lack of buying momentum. The company reported a net loss of $37.9 million for the first half of 2026, which is a substantial increase from the previous year's loss. Additionally, the stock has a year-to-date change of -74.94%, suggesting a severe decline in value. While there are positive catalysts such as FDA Fast Track designation for Givastomig, the financial performance and high losses pose significant risks, making it a sell at this time.

NovaBridge Biosciences (NBP) last closed at $0.9081, losing -10.09%. These facts feed the 1-day and 1-week NBP price prediction above.